Zocor Lawsuit News | Zocor Lawsuit Center - Part 2

New Study Shows Anti-Cancer Side Effects of Zocor

Neal Donaghy | January 29th, 2013
Zocor Settlements

Zocor is the brand-name for simvastatin, one of a group of drugs called HMG CoA reductase inhibitors – commonly known as statins. The medication works by reducing the body’s levels of ‘bad’ cholesterol and increasing ‘good’ cholesterol. Zocor and other statins are usually prescribed to lower a patient’s risk of stroke and heart disease. A recent study suggests some statins… Read more »

Merck Expects IMPROVE-IT Study Results By 2014

Ava Lawson | January 15th, 2013
Zocor FDA warning

Zocor , a cholesterol-lowering statin, has been the subject of controversy in recent years, as many patients who took the medication reported health complications, ranging from gastrointestinal side effects and liver damage to severe muscle injury. Zocor manufacturer, Merck & Co. recently announced that it expects preliminary data from its IMPROVE-IT study by 2014. The question of the large-scale clinical trial,… Read more »

Rhabdomyolysis Linked to Kidney Failure In Zocor Users

Emma Gonzalez | December 19th, 2012
ZOCOR Muscle Injury Lawsuit

Rhabdomyolysis is a type of severe and rare muscle injury that has been linked to high dosages of statin drugs, including Zocor and its generic, simvastatin. In the event of rhabdomyolysis, a lawsuit can help recover damages for medical expenses, lost wages, and even wrongful death. People who have suffered muscle injury or rhabdomyolysis after using the cholesterol drug have… Read more »

Plaintiff Seeks Damages for Zocor Muscle Injury

W.L. Meyers | December 4th, 2012
Zocor Side Effects Victim

In a new Zocor lawsuit a man claims that the cholesterol lowering medication caused him to suffer serious muscle damage. Plaintiff Robert Rosenberg filed his complaint on October 5, 2012, in the U.S. District Court, District of Nevada, and is seeking compensation based on a number of causes of action including negligence, fraud, strict product liability and breach of express warranty. Zocor… Read more »

U.K. Agency Limits Zocor Doses To Help Prevent Muscle Injury

W.L. Meyers | November 20th, 2012
Zocor Warnings

The U.K.’s Medicines and Healthcare Regulatory Agency (MHRA) has opted to slash the highest legal doses of Zocor and its generic equivalent, simvastatin, in half, in order to help lower the risks of muscle injury associated with the product. On October 29, the agency announced that it would limit doses of the cholesterol-regulating drug to 20 milligrams. High doses of… Read more »